Clinical Trials Logo

Clinical Trial Summary

Assessment of the clinical safety and performance of the Orsiro drug-eluting stent in a real world setting in patients with small vessels with reference vessel diameter ≤2.75 mm.


Clinical Trial Description

Prospective, single-arm, multi-center, all-comers registry with clinical follow-up visits at the hospital or by phone at 6 and 12 months post-procedure. A minimum of 1000 patients will be enrolled in approximately 15 sites in Brazil, including at least 415 patients with reference vessel diameter ≤2.75 mm as assessed by online QCA. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03600948
Study type Observational
Source Biotronik AG
Contact
Status Terminated
Phase
Start date August 27, 2018
Completion date October 6, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05544864 - Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5 N/A
Recruiting NCT04573660 - Abbott Vascular Medical Device Registry
Not yet recruiting NCT03588962 - Metal Allergy In-Stent Restenosis Study N/A